Top FDA Drug Official Resigns Amid Federal Probe
The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.
The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.
Discover how the FDA's landmark approval of Casgevy, the first CRISPR-based treatment, is transforming genetic medicine and offering hope for sickle cell patients.